Ashburnham, MA, United States of America

Bruce Charles Gomes

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 241(Granted Patents)


Location History:

  • Wilmington, DE (US) (2007)
  • Ashburnham, MA (US) (2011 - 2015)

Company Filing History:


Years Active: 2007-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Bruce Charles Gomes: Innovator Addressing Critical Challenges in Multiple Industries

Introduction:

Bruce Charles Gomes is an accomplished innovator whose career has been marked by numerous milestones and significant contributions across various industries. With a commitment to excellence and out-of-the-box thinking, Gomes has developed innovative solutions that have made a positive impact on society. This article will explore his latest patents, career highlights, notable collaborations, and conclude with an overview of his remarkable achievements.

Latest Patents:

Gomes boasts an impressive portfolio of patents, with his latest inventions focused on important healthcare advancements. Two notable patents are:

1. PCSK9 Antagonists:

Gomes's invention provides antibodies, antigen-binding portions thereof, and aptamers that bind to a protein called proprotein convertase subtilisin kexin type 9 (PCSK9). These antibodies effectively reduce LDL-cholesterol levels and hold potential for the treatment and prevention of cardiovascular diseases, particularly hypercholesterolemia.

2. Anti-PCSK9 Antibodies with pH Dependent Antigen Binding:

Gomes's groundbreaking patent introduces antibodies with pH-dependent binding to their target antigen. These antibodies show higher affinity for antigen binding at physiological pH (pH 7.4) compared to endosomal pH (pH 6.0 or 5.5). This unique property prolongs antibody half-life, enhances antigen clearance when bound to the antibody, and can be of significant value in targeting various pathogenic antigens such as IgE, DKK1, C5, SOST, and GMCSF receptor.

Career Highlights:

Throughout his career, Gomes has achieved several career highlights, demonstrating his expertise and dedication to innovation. Notable milestones include:

1. Rinat Neuroscience Corporation:

Gomes contributed to the advancements in neuroscience at Rinat Neuroscience Corporation. His work involved pioneering research and development in the field, resulting in substantial breakthroughs in neurological therapies.

2. Pfizer Corporation:

Gomes also played a pivotal role in the innovation efforts at Pfizer Corporation. As a highly skilled researcher, he contributed to the development of novel pharmaceutical products and therapeutic solutions, making a significant impact on the medical industry.

Collaborations:

Gomes has worked alongside accomplished professionals in his career, collaborating with experts who share his passion for innovation. Notable co-workers include:

1. Hong Liang:

Hong Liang is a prominent figure in the pharmaceutical research industry, known for her expertise in developing cutting-edge drug therapies. Gomes's collaboration with Liang at Pfizer Corporation likely contributed to their collective achievements in the field.

2. Javier Fernando Chaparro Riggers:

Javier Fernando Chaparro Riggers is a respected innovator focused on the intersection of technology and healthcare. Gomes's collaboration with Chaparro Riggers may have resulted in groundbreaking advancements and novel approaches to addressing critical healthcare challenges.

Conclusion:

Bruce Charles Gomes is an exceptional innovator whose expertise and innovative thinking have propelled him to achieve remarkable milestones throughout his career. His latest patents in the field of medical research demonstrate his dedication to developing solutions that address critical challenges in healthcare. Gomes's collaborations with accomplished individuals further highlight his ability to work effectively within multidisciplinary teams. As Gomes continues to push boundaries and contribute to society, his impact is sure to be felt across various industries for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…